CREDIT SUISSE AG/ - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 19 filers reported holding PTC THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$2,135,000
-43.9%
2,000,000
-43.3%
0.00%
-50.0%
Q2 2021$3,808,000
+34.3%
3,525,000
+41.7%
0.00%
+100.0%
Q1 2021$2,836,000
-12.0%
2,488,000
-0.5%
0.00%
-50.0%
Q4 2020$3,222,000
+14.7%
2,500,0000.0%0.00%0.0%
Q3 2020$2,808,000
-58.5%
2,500,000
-57.5%
0.00%
-60.0%
Q2 2020$6,768,000
-52.7%
5,883,000
-52.5%
0.01%
-50.0%
Q4 2019$14,296,000
+1742.3%
12,393,000
+1552.4%
0.01%
+900.0%
Q3 2019$776,000
-63.4%
750,000
-61.0%
0.00%
-50.0%
Q2 2019$2,122,000
-72.8%
1,925,000
-74.5%
0.00%
-71.4%
Q1 2019$7,803,000
-35.1%
7,535,000
-37.8%
0.01%
-46.2%
Q4 2018$12,029,000
-21.4%
12,105,000
-9.4%
0.01%
-7.1%
Q3 2018$15,307,000
+37.6%
13,362,000
+18.6%
0.01%
+27.3%
Q2 2018$11,127,000
+79.6%
11,262,000
+66.5%
0.01%
+83.3%
Q1 2018$6,197,000
+4.4%
6,762,000
-12.9%
0.01%
+20.0%
Q4 2017$5,938,000
-42.5%
7,762,000
-39.6%
0.01%
-50.0%
Q3 2017$10,325,000
+233.2%
12,855,000
+221.0%
0.01%
+233.3%
Q2 2017$3,099,000
+35.7%
4,005,000
+10.2%
0.00%
+50.0%
Q1 2017$2,283,0003,635,0000.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 31,204,000$31,610,0000.98%
Opti Capital Management, LP 8,000,000$8,206,0000.66%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 14,527,000$15,076,0000.34%
TENOR CAPITAL MANAGEMENT Co., L.P. 15,519,000$15,848,0000.31%
CSS LLC/IL 7,007,000$7,112,0000.26%
WOLVERINE ASSET MANAGEMENT LLC 17,479,000$17,762,0000.17%
LMR Partners LLP 9,500,000$9,933,0000.12%
PALISADE CAPITAL MANAGEMENT, LP 4,672,000$4,858,0000.11%
Verition Fund Management LLC 8,091,000$8,233,0000.10%
Aequim Alternative Investments LP 2,000,000$2,035,0000.05%
View complete list of PTC THERAPEUTICS INC shareholders